Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study

Table 2 Antibiotic sensitivity of multidrug-resistant gram negative bacilli (n = 128)

Antimicrobial agents	Resistance (%) among bacterial isolates
Antimicrobial agents	Acinetobacter spp (n = 52)	Pseudomonas spp (n = 27)	Klebsiella pneumoniae (n = 36)	Escherichiacoli (n = 7)	Enterobacter spp (n = 4)	Citrobacter spp (n = 2)
Levofloxacin	85	88	73	57	100	50
Ciprofloxacin	92	90	82	86	100	100
Amikacin	93	89	76	71	100	50
Gentamycin	93	89	79	71	100	50
Tobramycin	–	87	–	–	–	–
Chloramphenicol	–	–	73	57	100	0
Cotrimoxazole	90	–	73	71	100	50
Ampicillin	–	–	–	100	100	100
Piperacillin	93	90	79		100	100
Piperacillin- Tazobactam	86	82	73	100	100	100
Amoxicillin-clavulanate	–	–	76	100	100	100
Ceftazidime	93	92	92	100	100	100
Cefotaxime	93	92	92	100	100	100
Cefepime	87	90	86	100	100	100
Imipenem	81	82	69	14	100	0
Tigecycline	58	63	57	14	67	0
Polymixin B	0	0	0	0	0	0
Colistin Sulphate	0	0	0	0	0	0

ISSN: 2047-2994